FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely, oncology, and can be used in order to determine the metastatic potential of invasive breast cancer. For this purpose, the degree of severity of the following signs of the change in the desmoplastic stroma is assessed using preparations that are prepared for morphological examination of the surgical material of the mammary gland suffering from the invasive protocol cancer: collagen fiber bundles separation and their decay; presence of the areas with the change in the physico-chemical properties of collagen fibers; increase in the content of neutral glycoproteins in the areas of destruction of collagen fibers; decrease in the content of sulfated glycosaminoglycans in the desmoplastic stroma; severity of infiltration with lympho-histiocytic elements; edema of the extracellular matrix in the infiltration zone. Absence of each of the above mentioned characteristics is estimated by zero points, insignificant, moderate and pronounced manifestation of each of these characteristics is assessed by one, three and seven points, respectively. Then the points are summarized the according to all the above mentioned characteristics and when the sum of points reaches 15 and higher, the conclusion is made about the high metastatic potential, and if the sum of points is 14 or less, the conclusion is made about the low metastatic potential of the breast Ifor for this patient. Sensitivity of the presented method makes 0.857, the specificity is 0.769, and the accuracy of the method is 0.788.
EFFECT: invention provides for the possibility of determining the metastatic potential of this type of tumor, which is important for selecting the further tactics of treating patients.
11 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING METASTATIC POTENTIAL OF INVASIVE BREAST CANCER AND COMPOSITION FOR IMPLEMENTATION THEREOF | 2018 |
|
RU2697055C1 |
METHOD FOR PREDICTING RISK OF LYMPHATIC CANCER SPREAD IN BREAST CANCER BASED ON YKL-39 PROTEIN GENE EXPRESSION | 2016 |
|
RU2632115C1 |
METHOD OF PREDICTING NODAL METASTASIS IN TWO-WAY SYNCHRONOUS INVASIVE CARCINOMA OF NON-SPECIFIC TYPE OF MAMMARY GLANDS | 2015 |
|
RU2578462C1 |
METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANIED BY INVASIVE NONSPECIFIC TRIPLE-NEGATIVE BREAST CANCER | 2014 |
|
RU2558860C1 |
METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN DOUBLE-SIDED SYNCHRONOUS INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2015 |
|
RU2589287C1 |
METHOD FOR PREDICTING FIVE-YEAR SURVIVAL RATE IN PATIENTS WITH INFILTRATING BREAST CANCER BY DETERMINING TOTAL SCORE OF MALIGNANCY | 2013 |
|
RU2547561C1 |
METHOD OF PREDICTING HIGH RISK OF REGIONAL METASTASIS IN BREAST CANCER | 2023 |
|
RU2816441C1 |
METHOD OF PREDICTING HEMATOGENOUS METASTASIS IN INVASIVE CARCINOMA OF NONSPECIFIC TYPE OF MAMMARY GLAND BASED ON DETERMINATION OF DIFFERENT POPULATIONS OF CIRCULATING TUMOR CELLS IN BLOOD BEFORE TREATMENT | 2018 |
|
RU2678202C1 |
METHOD FOR PREDICTION OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH THREE-TIMES NEGATIVE MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2623118C1 |
METHOD FOR PREDICTING LYMPHATIC CANCER SPREAD IN PANCREATIC DUCTUAL ADENOCARCINOMA | 2017 |
|
RU2648442C1 |
Authors
Dates
2018-03-07—Published
2017-04-26—Filed